| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRSL.2007.09.006 |
| P698 | PubMed publication ID | 18279810 |
| P2093 | author name string | Judy A King | |
| Solomon F Ofori-Acquah | |||
| P2860 | cites work | Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells | Q24298706 |
| Relevance of CD6-mediated interactions in T cell activation and proliferation | Q24300571 | ||
| Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand | Q24319426 | ||
| Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM | Q24675053 | ||
| Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator | Q24806155 | ||
| Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin | Q28144710 | ||
| Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction | Q28212934 | ||
| ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions | Q28217430 | ||
| CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on gamma-interferon activated keratinocytes | Q28259481 | ||
| Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis | Q28261479 | ||
| MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma | Q28262234 | ||
| Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity | Q28275446 | ||
| Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function | Q28288857 | ||
| Axon fasciculation defects and retinal dysplasias in mice lacking the immunoglobulin superfamily adhesion molecule BEN/ALCAM/SC1 | Q28588934 | ||
| Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding | Q28593326 | ||
| Isolation, primary structure characterization and identification of the glycosylation pattern of recombinant goldfish neurolin, a neuronal cell adhesion protein | Q30679529 | ||
| Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation | Q32066783 | ||
| Molecular cloning and expression of a novel adhesion molecule, SC1. | Q33421252 | ||
| Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens | Q34544377 | ||
| Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration | Q34734672 | ||
| Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer | Q35769956 | ||
| Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration? | Q36178357 | ||
| Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells | Q36364656 | ||
| Neurolin, a cell surface glycoprotein on growing retinal axons in the goldfish visual system, is reexpressed during retinal axonal regeneration | Q36531340 | ||
| v-rel Induces ectopic expression of an adhesion molecule, DM-GRASP, during B-lymphoma development | Q36550173 | ||
| BEN, a surface glycoprotein of the immunoglobulin superfamily, is expressed in a variety of developing systems | Q37052365 | ||
| An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen | Q40313659 | ||
| The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry | Q41183840 | ||
| CD6-ligand interactions: a paradigm for SRCR domain function? | Q41633008 | ||
| ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival | Q41983868 | ||
| Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin | Q42026021 | ||
| Distribution and characteristics of a 90 kDa protein, KG-CAM, in the rat CNS. | Q42494517 | ||
| Frontline: Optimal T cell activation requires the engagement of CD6 and CD166. | Q47867827 | ||
| Cloning and characterization of HB2, a candidate high density lipoprotein receptor. Sequence homology with members of the immunoglobulin superfamily of membrane proteins | Q48047451 | ||
| The molecular cloning and characterization of potential chick DM-GRASP homologs in zebrafish and mouse | Q48081066 | ||
| Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction. | Q49043970 | ||
| Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration. | Q51808032 | ||
| Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. | Q52941765 | ||
| Increased expression of stem cell markers in malignant melanoma. | Q53339373 | ||
| DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension | Q67945477 | ||
| Cancer Invasion and Metastasis | Q72863702 | ||
| Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis | Q73308234 | ||
| A candidate high density lipoprotein (HDL) receptor, HB2, with possible multiple functions shows sequence homology with adhesion molecules | Q77212971 | ||
| P433 | issue | 3 | |
| P921 | main subject | cell adhesion | Q187640 |
| P304 | page(s) | 122-128 | |
| P577 | publication date | 2007-10-23 | |
| P1433 | published in | Translational Research | Q15761127 |
| P1476 | title | Activated leukocyte cell adhesion molecule: a new paradox in cancer | |
| P478 | volume | 151 |
| Q33343004 | A mouse to human search for plasma proteome changes associated with pancreatic tumor development |
| Q33634142 | A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth |
| Q39615435 | A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker |
| Q39715463 | ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients |
| Q34321201 | ALCAM (CD166) expression and serum levels in pancreatic cancer |
| Q89738593 | ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium |
| Q39068346 | ALCAM is indirectly modulated by miR-125b in MCF7 cells. |
| Q34321331 | ALCAM regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells. |
| Q52571266 | ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer. |
| Q39262727 | ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9. |
| Q34112011 | ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone |
| Q35609716 | ALCAM: Basis Sequence: Mouse |
| Q36089828 | Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Saudi Breast Cancer Patients as Prognostic and Predictive Indicator. |
| Q39026693 | Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer? |
| Q54329531 | Activated leukocyte cell adhesion molecule modulates neurotrophin signaling. |
| Q39241466 | Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors |
| Q37095851 | Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer. |
| Q37319929 | Alcam regulates long-term hematopoietic stem cell engraftment and self-renewal. |
| Q41813406 | Alcama mediates Edn1 signaling during zebrafish cartilage morphogenesis |
| Q64105733 | Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma |
| Q58874863 | Antibodies in Phase III Studies for Immunological Disorders |
| Q35234354 | Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma |
| Q39615928 | CD166 expression in dentigerous cyst, keratocystic odontogenic tumor and ameloblastoma. |
| Q41868074 | CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion |
| Q38678576 | Can recurrences be predicted in craniopharyngiomas? β-catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases. |
| Q37738855 | Cancer stem-like cell related protein CD166 degrades through E3 ubiquitin ligase CHIP in head and neck cancer |
| Q28468626 | Capsaicin triggers autophagic cell survival which drives epithelial mesenchymal transition and chemoresistance in bladder cancer cells in an Hedgehog-dependent manner |
| Q51752872 | Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression. |
| Q26771983 | Cell Adhesion Molecules and Ubiquitination-Functions and Significance |
| Q33896152 | Characterization and functionality of proliferative human Sertoli cells |
| Q41353471 | Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer |
| Q51749879 | Clinical implication of CD166 expression in gastric cancer |
| Q35486869 | Clinical implication of CD166 expression in salivary gland tumor. |
| Q34807135 | Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression. |
| Q42021757 | Cloning of the human activated leukocyte cell adhesion molecule promoter and identification of its tissue-independent transcriptional activation by Sp1. |
| Q34309546 | Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer. |
| Q36248528 | Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor |
| Q34313174 | Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific ⁶⁴Cu-DOTA conjugation |
| Q36175628 | Expression and Role of CD166 in the Chronic Kidney Disease |
| Q36395604 | Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome |
| Q34713009 | Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma |
| Q36215986 | Generation of novel monoclonal antibodies for the enrichment and characterization of human corneal endothelial cells (hCENC) necessary for the treatment of corneal endothelial blindness |
| Q37613200 | Genetics of cortisol secretion and depressive symptoms: a candidate gene and genome wide association approach |
| Q87409486 | HMMC-1, a human monoclonal antibody to fucosylated core 1 O-glycan, suppresses growth of uterine endometrial cancer cells |
| Q36725887 | Hierarchical organization of osteoblasts reveals the significant role of CD166 in hematopoietic stem cell maintenance and function |
| Q37885284 | Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands |
| Q34374335 | Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells |
| Q26784533 | Lesser-Known Molecules in Ovarian Carcinogenesis |
| Q34902401 | Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis |
| Q39647270 | Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer |
| Q28299575 | MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro |
| Q91694988 | Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166 |
| Q39110080 | Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes |
| Q35809642 | Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients. |
| Q35432364 | Proteomic Characterization of Cerebrospinal Fluid from Ataxia-Telangiectasia (A-T) Patients Using a LC/MS-Based Label-Free Protein Quantification Technology |
| Q38409707 | Proteomic Identification of Cysteine Cathepsin Substrates Shed from the Surface of Cancer Cells. |
| Q38730494 | Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases |
| Q34220083 | Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients |
| Q37800163 | Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain |
| Q34402141 | Should EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition? |
| Q36910768 | Stable isotope labeling in zebrafish allows in vivo monitoring of cardiac morphogenesis |
| Q37681488 | Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients |
| Q35095152 | Targeting tumor cell motility to prevent metastasis. |
| Q42780810 | The Aryl-Hydrocarbon Receptor Protein Interaction Network (AHR-PIN) as Identified by Tandem Affinity Purification (TAP) and Mass Spectrometry |
| Q94538371 | The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker |
| Q39766239 | Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts |
| Q38150869 | Why is melanoma so metastatic? |
Search more.